Privi Speciality Chemicals Limited has announced the withdrawal of its amalgamation scheme involving two subsidiaries, Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited. The decision was made by the company's Board of Directors during a meeting held on November 15, 2025.

Key Details of the Withdrawal

The company has provided the following information regarding the withdrawal:

Board Meeting and Decision

The Board of Directors convened on November 15, 2025, from 11:00 a.m. to 11:45 a.m., to consider and approve the withdrawal of the amalgamation scheme. This decision was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company's Statement on Impact

Privi Speciality Chemicals has stated that the withdrawal is not expected to have any adverse impact on the company. The primary effect of this decision is a delay in the filing process. The company has expressed its intention to refile the application for the amalgamation scheme in the near future.

Regulatory Compliance

The company has submitted the required information to the stock exchanges as per SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. This ensures transparency and compliance with regulatory requirements.

Conclusion

While the withdrawal of the amalgamation scheme represents a temporary setback in Privi Speciality Chemicals' corporate restructuring plans, the company remains committed to pursuing the amalgamation. Investors and stakeholders will be keenly watching for the refiling of the application and any subsequent developments in this corporate action.

Privi Speciality Chemicals Limited has announced exceptional financial results for the second quarter of fiscal year 2026, showcasing robust growth and improved profitability.

Financial Highlights

The company reported a total income of Rs. 678.82 crores for Q2 FY26, marking a significant 26% year-on-year growth. This performance was complemented by a substantial increase in EBITDA, which reached Rs. 182.14 crores, representing a remarkable 59% year-on-year growth. The EBITDA margin for the quarter stood at 26.83%.

Profit after tax (PAT) for Q2 FY26 more than doubled to Rs. 90.21 crores, compared to Rs. 44.84 crores in the same quarter of the previous fiscal year.

H1 FY26 Performance

For the first half of FY26, Privi Speciality Chemicals achieved:

Operational Highlights

The company's strong performance can be attributed to several factors:

1. Volume Growth: The revenue increase was primarily driven by a 17% growth in sales volume.
2. Capacity Utilization: Privi achieved a high capacity utilization of 92% during H1 FY26.
3. Product Mix: The company's focus on flagship products and new product contributions has yielded positive results.
4. Operational Excellence: Improvements in process yields, lower operating costs, and optimum manpower utilization have contributed to margin expansion.

Future Outlook

Privi Speciality Chemicals has outlined an ambitious vision for the next three to four years:

• Revenue Target: Rs. 5,000 crores
• EBITDA Target: Rs. 1,000 crores

To achieve these goals, the company is focusing on:

1. Capacity Expansion: An additional 6,000 metric tons of capacity is expected to be operational by the end of December 2025, bringing the total capacity to 54,000 metric tons.
2. Product Diversification: The company is developing a robust pipeline of new products, including both large-volume offerings and specialty molecules with higher margins.
3. Sustainability Focus: Privi's commitment to sustainability has been recognized with awards, including a first prize at the IFEAT 2025 conference and a Platinum rating from EcoVadis.

Management Commentary

Mr. Narayan S. Iyer, Chief Financial Officer, stated, "Our performance was driven by increasing demand across the product portfolio and a favorable product mix. We remain confident that Privi is well-positioned to sustain its growth momentum in the coming periods."

Mr. Sanjeev Patil, Executive Vice President, added, "We are working on multiple products to reduce our dependency on any particular product to around 10% max of our revenue. Our growth strategy includes a mix of volume-driven products and highly specialized chemicals."

With its strong financial performance, strategic expansion plans, and focus on sustainability, Privi Speciality Chemicals appears well-positioned to capitalize on the growing demand in the fragrance and specialty chemicals market.